Funding & VC

Traitomic raises €20 million to expand FIND-IT platform

Traitomic raised €20 million in Series A funding led by Sofinnova Partners to expand FIND-IT, grow its team and develop applications for plants and microorganisms.

By Daniel Okafor

4 min read

Traitomic Raises €20 Million To Expand FIND-IT Trait Development Platform
Traitomic Raises €20 Million To Expand FIND-IT Trait Development Platformjarmoluk / pixabay

What's News

  • Traitomic raised €20 million in Series A financing.
  • Sofinnova Partners led the financing round.
  • The Export and Investment Fund of Denmark, The Footprint Firm, Nordic Foodtech VC, PSV Hafnium and SVG Ventures THRIVE participated.
  • The proceeds will support international expansion, workforce growth and new FIND-IT applications.
  • Carlsberg Group has continued to support Traitomic.

Traitomic raised €20 million in Series A financing to speed the development and commercialization of FIND-IT, a biological trait discovery platform for plants and microorganisms. Sofinnova Partners led the round. The Export and Investment Fund of Denmark, The Footprint Firm, Nordic Foodtech VC, PSV Hafnium and SVG Ventures THRIVE participated.

Traitomic said the proceeds will fund international expansion, workforce growth and new applications for the proprietary platform. The financing gives Traitomic three jobs at once: widen its market, add specialist capacity and turn biological research into products and processes that customers can adopt at commercial scale.

None of those jobs is finished. Traitomic said commercialization depends on proving that identified traits deliver reproducible gains in real crops, growing environments and manufacturing systems. The announcement provides no valuation, closing date, headcount target or product-level revenue forecast.

What does FIND-IT actually do?

Plants respond to environmental conditions, develop in specific ways and carry traits that affect performance. Traitomic said FIND-IT helps researchers and commercial partners identify potentially valuable biological characteristics and move them toward practical applications.

Discovery can require extensive research, testing and validation before a trait shows a commercially meaningful benefit, Traitomic said. In practical terms, FIND-IT sits upstream of the products and processes the company wants to develop. Traitomic said in the financing announcement: “Traitomic is developing technologies intended to make this discovery and development process more efficient and applicable across multiple markets.”

In agriculture, candidate traits may improve resilience under difficult growing conditions, product quality and resource efficiency. Traitomic also sees potential in plant development, crop consistency, processing performance and product differentiation.

For microorganisms, Traitomic is developing applications for fermentation, industrial ingredients and biological manufacturing. Better biological performance may affect production efficiency, output consistency and the characteristics of finished products.

Why does Traitomic see demand for faster trait discovery?

Agricultural producers face changing weather, limited natural resources and pressure to maintain reliable yields, Traitomic said. Agricultural and industrial companies also face pressure to raise productivity while reducing resource consumption and adapting to changing environmental conditions.

Traitomic’s broader goal is to make trait discovery more effective for organizations pursuing productivity and sustainability gains. The company frames biological innovation around naturally occurring or developed traits that can improve crops and microorganisms.

Useful traits can improve crop performance under specific conditions, but their commercial value depends on measurable benefits in relevant crops, growing environments and production systems. A trait must work in the target environment, not merely in controlled research, Traitomic said.

The announcement provides no crop-specific field results, time-to-market estimates or contract values. Industrial buyers face a similar test. Traitomic said successful commercialization may depend on validating improvements under practical manufacturing conditions, including the consistency required for biological production systems.

Where will the €20 million go?

Traitomic plans to use the money for international expansion, hiring and further development of FIND-IT. The company will pursue agricultural, food technology and industrial biotechnology businesses across different markets.

Expanding the platform may require Traitomic to adapt its discovery and development methods to different organisms, traits and commercial requirements. Traitomic said new applications could extend beyond its initial markets into agricultural inputs, crop development, food production and other biologically driven industries for partners across multiple markets.

The financing therefore funds reach and product development at the same time. The company must still turn discoveries into commercially valuable products and processes, Traitomic said.

What does Carlsberg Group add?

Traitomic cited continued support from Carlsberg Group as evidence of its connections to established industries that depend on biological processes. Traitomic said the relationship with the global food and beverage group remains ongoing.

The announcement provides neither the size nor the terms of that support. It also names no specific Carlsberg program using FIND-IT, so the disclosed evidence remains a corporate relationship rather than a quantified deployment tied to a specific customer operation.

That distinction matters because Traitomic is asking investors to fund a platform with applications across agriculture and industrial biotechnology. Funding expands capacity, but it does not replace customer-level proof.

What must happen next?

Traitomic said: “The company will need to demonstrate that identified traits can deliver reproducible performance improvements under relevant real-world conditions.” In agriculture, that means evaluation across different crops, environments and production systems.

For industrial uses, it means validating improvements under practical manufacturing conditions. Traitomic said even incremental gains could support more efficient operations, provided the platform validates them in the environments where customers use them.

The €20 million buys Traitomic time, staff and further FIND-IT development. Its next proof point is replicated performance across crops, growing environments and manufacturing systems, not a broader list of potential applications. Traitomic’s next test is whether FIND-IT can convert biological discoveries into repeatable gains across different crops, growing environments and manufacturing systems, the conditions it says commercialization requires.

Source: pulse2.com

Share this article:

More from Daniel Okafor

Daniel Okafor

Show full bio

Correspondent covering money, funding and market shifts around entrepreneurship, startups and venture funding at Business Bearings.

2,391 articles

Related articles

« Previous articleNext article »